Filing Flows › InfuSystem Holdings (INFU) › How it makes money
How InfuSystem Holdings (INFU) makes money
InfuSystem Holdings (INFU) made $37.6M of revenue in the third quarter 2026 (Q3 2026), +3% from a year earlier. Patient Services brought in $25.8M (69%); Device Solutions brought in $11.8M (31%). Of every dollar of revenue, 58¢ was left as gross profit, 13¢ was left as operating profit, 8¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Patient Services | $25.8M | 68.7% | — | +15% |
| Device Solutions | $11.8M | 31.3% | — | -17% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $37.6M | 100.0% |
| Cost of revenue | $15.9M | 42.2% |
| Gross profit | $21.7M | 57.8% |
| Operating expenses | $17.0M | 45.2% |
| Operating profit | $4.7M | 12.6% |
| Income tax | $1.4M | 3.7% |
| Net earnings | $3.2M | 8.4% |
| Operating cash flow | $10.3M | 27.5% |
| Free cash flow | $10.3M | 27.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $37.6M | +3% |
| Q2 2026 | $36.9M | +3% |
| Q1 2026 | $33.7M | -3% |
| Q4 2025 | $36.2M | +7% |
| Q3 2025 | $36.5M | +3% |
| Q2 2025 | $36.0M | +7% |
| Q1 2025 | $34.7M | +8% |
From InfuSystem Holdings' 8-K filed Nov 5, 2026 (on EDGAR).
Questions
How does InfuSystem Holdings make money?
InfuSystem Holdings (INFU) made $37.6M of revenue in the third quarter 2026 (Q3 2026), +3% from a year earlier. Patient Services brought in $25.8M (69%); Device Solutions brought in $11.8M (31%). Of every dollar of revenue, 58¢ was left as gross profit, 13¢ was left as operating profit, 8¢ was left as net earnings.
What is InfuSystem Holdings' biggest business?
Patient Services: $25.8M in the third quarter 2026, 69% of revenue, +15% from a year earlier.
What is InfuSystem Holdings' profit margin?
Net earnings were $3.2M, 8.4% of revenue, in the third quarter 2026; the operating margin was 12.6%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.